BridgeBio Oncology Therapeutics Inc. ( BBOT) - Stock Earnings
BBOT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -38.8 million USD | — USD |
| 2026Q1 | -42.1 million USD | — USD |
| 2026Q2 | -56.5 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
BBOT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -64.7 million USD | — USD |
| 2024 | -74.3 million USD | — USD |
| 2025 | -134.0 million USD | — USD |
| 2026 Est. | — | — |
BBOT
Price: $9.08
52 week price:
Earnings Per Share: -2.27 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 726.4 million